Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Cancer Medicine
|
October 23, 2019
The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort
Jin Ho Choi, Sang Hyub Lee, Gunn Huh, et al.
BMC Cancer
|
January 7, 2019
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
Min Su You, Ji Kon Ryu, Young Hoon Choi, et al.
Endoscopic Ultrasound
|
January 26, 2026
Comparison of 4 first-line endoscopic biliary drainage modalities in distal malignant biliary obstruction: A systematic review and network meta-analysis
Gunn Huh, Won-Mook Choi, Jung Bok Lee, et al.
Therapeutic Advances in Medical Oncology
|
November 18, 2021
Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
Gunn Huh, Hee Seung Lee, Jin Ho Choi, et al.
BMC Cancer
|
May 12, 2021
Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach
Jung Won Chun, Sang Hyub Lee, Joo Seong Kim, et al.
BMC Cancer
|
September 24, 2020
High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
Gunn Huh, Ji Kon Ryu, Jung Won Chun, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
August 2, 2025
Outcomes of Patients With Unresectable Cholangiocarcinoma After Portal Vein Embolization: A Propensity Score-Matched Analysis
Ho Seung Lee, Tae Jun Song, Sung Hyun Cho, et al.
Clinical and Molecular Hepatology
|
September 24, 2024
Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial
Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, et al.
BMC Gastroenterology
|
June 1, 2022
The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
Joo Seong Kim, Sang Hyub Lee, Namyoung Park, et al.
BMC Gastroenterology
|
April 18, 2021
Optimal timing of endoscopic retrograde cholangiopancreatography for acute cholangitis associated with distal malignant biliary obstruction
Namyoung Park, Sang Hyub Lee, Min Su You, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Cancer Medicine
|
October 23, 2019
The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort
Jin Ho Choi, Sang Hyub Lee, Gunn Huh, et al.
BMC Cancer
|
January 7, 2019
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
Min Su You, Ji Kon Ryu, Young Hoon Choi, et al.
Endoscopic Ultrasound
|
January 26, 2026
Comparison of 4 first-line endoscopic biliary drainage modalities in distal malignant biliary obstruction: A systematic review and network meta-analysis
Gunn Huh, Won-Mook Choi, Jung Bok Lee, et al.
Therapeutic Advances in Medical Oncology
|
November 18, 2021
Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
Gunn Huh, Hee Seung Lee, Jin Ho Choi, et al.
BMC Cancer
|
May 12, 2021
Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach
Jung Won Chun, Sang Hyub Lee, Joo Seong Kim, et al.
BMC Cancer
|
September 24, 2020
High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
Gunn Huh, Ji Kon Ryu, Jung Won Chun, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
August 2, 2025
Outcomes of Patients With Unresectable Cholangiocarcinoma After Portal Vein Embolization: A Propensity Score-Matched Analysis
Ho Seung Lee, Tae Jun Song, Sung Hyun Cho, et al.
Clinical and Molecular Hepatology
|
September 24, 2024
Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial
Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, et al.
BMC Gastroenterology
|
June 1, 2022
The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
Joo Seong Kim, Sang Hyub Lee, Namyoung Park, et al.
BMC Gastroenterology
|
April 18, 2021
Optimal timing of endoscopic retrograde cholangiopancreatography for acute cholangitis associated with distal malignant biliary obstruction
Namyoung Park, Sang Hyub Lee, Min Su You, et al.
Page
of 4